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Background: The proposal of a 4-year plan to integrate treatment of people with long term
medical conditions (LTCs) into the IAPT service (Department of Health, 2011) seeks for
research to understand the effectiveness of IAPT interventions for this patient group. Aim:
The aim of this service development pilot work was to develop an intervention that is effective
for people with Type 2 Diabetes Mellitus (T2DM). It was hypothesized that the standard IAPT
intervention would not be effective, but that it can be adapted so that it is effective both in
terms of mood and self-management of T2DM. Method: Clients (n = 95) who experienced
mild to moderate depression and/or anxiety and had a diagnosis of T2DM opted to attend.
The intervention was adapted over a series of cohorts from a standard Step 2 intervention.
A team of Psychological Wellbeing Practitioners (PWPs), a Clinical Health Psychologist
and a General Practitioner worked in collaboration, using outcomes measures and feedback
from service users and facilitators. Results: The standard IAPT Step 2 intervention met with
challenges when specifically targeting this client group. Using paired t-tests, the modified Step
2 intervention demonstrated significant improvements from pre- to postintervention measures
both in terms of psychological (n = 17) and physical (n = 9) outcomes. Conclusion: It is
concluded that it may be possible to modify a generic Step 2 IAPT intervention to demonstrate
improvements both in terms of psychological wellbeing and self-management of T2DM. The
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main adaptations were related to more targeted recruitment and linking of diabetes specifically
into the CBT model.
Keywords: IAPT, depression, anxiety, long term medical condition, diabetes, T2DM, Step 2,
wellbeing course.
Introduction
It is reported that 2.6 million people in the UK have diagnosed Type 2 Diabetes Mellitus
(T2DM), with an estimated further 0.5 million currently undiagnosed. Poor glycaemic control
(sustained high blood sugar levels) potentially leads to damage to essential organs including
eyes, kidneys, and peripheral nerves. This can result in disability and a reduction of quality
of life, or premature death reducing lifespan by 10–20 years. Recent research has also
demonstrated increased mortality rates with low levels of glycated haemoglobin (HbA1c)
(Currie et al., 2010). Patient focused care and supporting self-management remains the central
founding principle of optimizing diabetic control, with a current focus on markers of physical
health and early detection of complications. This is achieved by medication reviews, including
physical examination of the renal, podiatric and ophthalmological systems.
What is the role of depression and anxiety in self-management of T2DM?
There are a range of barriers to self-management, including mood. Anxiety and depression
are common in people with T2DM; with an increased risk of experiencing depression, about
twice that of the background rate (Anderson, Freedland, Clouse and Lustman, 2001; Ali,
Stone, Peters, Davie and Khunti, 2006) and a third of people with T2DM showing “mild to
severe” anxiety (Collins, Corcoran and Perry, 2009). Anxiety and depression can impact on a
person’s ability to self-care and self-manage their long-term condition (LTC), which in turn
can increase complication rates and disability; decreases quality of life; increases healthcare
use and cost; and increases risk of death (Lin et al., 2010; Edege and Ellis, 2010).
Research suggests that recognizing psychological distress, and dealing with common
mental health issues such as depression and anxiety are equally important but are unaddressed
(Diabetes UK, 2010; Snoek, Welch, Pouwer and Polonsky, 1995; Primary Care Diabetes
Society, 2011). The General Practitioners Quality Outcome Framework no longer requires
clinicians to ask about mental health during routine diabetic reviews, and there is no current
national target for assessing psychological need. Nor is there a specific service designed to
respond to this unmet need.
There is inconclusive evidence as to whether improving anxiety and depression leads to im-
provements in self-management, or whether interventions need to be focused specifically on
self-management. Research evidence suggests that cognitive behavioural therapy (CBT) is ef-
fective for people with LTCs regarding both psychological and physical measures, e.g. in pain
management (Gatchel, Peng, Peters, Fuchs and Turk, 2007; Morley, Eccleston and Williams
(1999); oncology (Hopko and Colman, 2010); and in diabetes management (Ismail, Winkley
and Rabe-Hesketh, 2004). However, much of this work focuses on issues such as education
of the condition, adjustment, adherence, relationship issues, as well as on depression/anxiety.
Furthermore, interventions are often run by specialists in the long term condition, such as
nurses; or by clinical health psychologists with expertise in working with this client group.
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The main proposer of the argument that interventions focusing on depression and anxiety
alone are inadequate is Lustman’s group who concluded that “depression in diabetes cannot
be managed as if it is an entity isolated from the medical illness” (Lustman and Clouse,
2002). Lin et al. (2004) have also argued that depression is not associated with preventative
behaviours such as home blood-glucose check and foot checks. It has been suggested
that psychological interventions that are effective in improving blood markers, as well as
psychological distress, include a range of approaches such as CBT, counselling, behaviour
modification and relaxation training (Ismail et al., 2004; Alam, Sturt and Winkley, 2009; van
der Feltz-Cornelis et al., 2010).
There is little research evidence supporting the argument that psychological work focusing
specifically on depression and anxiety is effective in the management of T2DM. However,
there have been some encouraging results from a few studies focusing on depression. For
example, Lamers, Jonkers, Bosna, Knottnerus and van Eijk (2011) demonstrated that nurse
led CBT interventions were effective, in older adults, in reducing distress about diabetes, and
showed significant differences in glycaemic control after 9 months. However, results were
significant only for higher-educated people, and were run by nurses with expertise in diabetes.
In a recent meta-analyses, Van Straten, Garaedts, Leeuw, Andersson and Cuijpers (2010)
found that interventions focusing on depression are as helpful for people with physical health
problems (including diabetes) as they are for healthy patients, when considering depression
as an outcome measure. However, in a systematic review, Markowitz, Gonzalez, Wilkinson
and Safren (2011) concluded that whilst showing improvements in depression, the efficacy of
interventions focusing on depression (including CBT) in improving glycaemic control was
mixed.
In summary, much of the research is inconclusive as to whether psychological interventions
focusing specifically on depression and anxiety may also be helpful with respect to the self-
management of diabetes. This raises questions around the Department of Health’s recent
4-year plan to integrate the treatment of people with LTCs into the IAPT programme
(Department of Health, 2011).
IAPT and work with people with LTC
The national IAPT programme, which focuses on depression and anxiety, has shown success
in delivering efficient and cost effective psychological services on a large scale nationally.
Interventions focusing on more severe and complex needs for this client group are usually
seen outside IAPT. In the case of people with LTCs, issues such as coping, adjustment and
adherence to medical regimens may be the focus of work by a specialist clinical health
psychologist. If IAPT are to offer interventions for people with physical health conditions, it
is crucial to understand whether interventions focusing specifically on depression and anxiety
are helpful to people with long term physical health problems. The aim of this study is to
develop a Step 2 IAPT intervention that is relevant to people with T2DM and to evaluate
the pilot data as to whether it is effective in improving anxiety and depression and self-
management among adults with T2DM, including overall glycaemic control (HbA1c).
A key objective for this study was to offer an evidence based, Step 2 intervention (NICE,
2009a,b; NICE, 2011a,b) provided by practitioners trained in treating common mental health
difficulties, and in line with this objective used a locally developed Wellbeing Course for
the treatment of depression and anxiety. The following report describes a systematic service
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development of this Step 2 intervention for people with T2DM. Developments of each phase
were based on outcome measures, and feedback from clinicians and clients. The aim was to
develop a Step 2 compliant intervention that demonstrates significant improvements in terms
of depression and anxiety, as well as in relation to self-management of the condition.
Method
Participants
People with T2DM (n = 1740) were sent a letter in collaboration with their registered GP
service (8 practices in total), inviting them to attend a Wellbeing Course for people who may
struggle with low mood and/or worry. Individuals were asked to contact the IAPT service by
telephone to opt in. During the service development, the intervention was adapted such that
patients were asked to opt in to an initial “telephone triage”. Across all phases of the service
development, 95 clients opted to attend the Wellbeing Course.
Measures
Outcome measures used included pre- and postintervention measures of general depression
(PHQ9) (Kroenke, Spitzer and Williams, 2001) and anxiety (GAD7) (Spitzer, Kroenke,
Williams and Löwe, 2006). The PHQ-9 is a 9-item self-report questionnaire that evaluates
symptoms of depression during the preceding 2 weeks. Scores can range from 0 (absence
of depressive symptoms) to 27 (severe depressive symptoms). Cut-off scores for depressive
symptoms are 5 (mild), 10 (moderate), 15 (moderate-severe) and 20 (severe). The GAD-7 is
a 7-item self-report questionnaire that evaluates symptoms of anxiety during the preceding
2 weeks. Scores can range from 0 (absence of anxiety symptoms) to 21 (severe anxiety
symptoms). Cut-off scores for anxiety symptoms are 5 (mild), 10 (moderate) and 15 (severe).
Additional outcome measures included physiological measures such as Glycosylated
haemoglobin (HbA1c), which is the main predictor of complications in diabetes. As
haemoglobin and glycosylated haemoglobin have a 90-day lifespan, there is a mandatory
3-month time lag between making any changes to diabetes management and changes in
HbA1c measures. Physiological measures therefore refer to results 3 months after the end of
each intervention.
The symptoms of depression and anxiety (such as feeling tired, moving slowly, as measured
by the PHQ and GAD) can overlap with the symptoms of long term conditions; for these
reasons, measures more specific to T2DM were introduced during the service development.
Psychological measures specific to diabetes were assessed using Diabetes Health Profile
(DHP) (Meadows et al., 2006), which measures three factors described as Psychological
Distress, Barriers to Activity and Disinhibited Eating; also the Summary of Diabetes Self-Care
Activities’ questionnaire (SDSCA) (Toobert, Hampson and Glasgow, 2000), which measures
the numbers of days per week that people adhere to regimens around diet, exercise, sugar
testing, not smoking, medication and foot care.
Statistical analyses
Analyses were conducted at each phase in order to make changes to improve the intervention
offered to this client group. The data were analyzed using SPSS (v. 13.0) with an a priori
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Table 1. Content of the standard Step 2 IAPT Wellbeing Group for
depression and anxiety
Session number Content of the session (1.5 hours)
Session 1 Introduction to the course
Goal setting
Introduction to Cognitive Behavioural Therapy
Session 2 Identifying unhelpful behaviours
Session 3 Changing behaviours
Session 4 Identifying unhelpful thoughts
Session 5 Challenging unhelpful thoughts
Session 6 Planning for the future
alpha level of 0.05 used for all statistical tests. The outcome measures related to depression,
anxiety, self-management of diabetes (all subfactors), and HbA1c for each phase met the
test for normality. Regarding the DHP, all measures met the test for normality apart from
preintervention measure of psychological distress in phase 3; and postintervention “Barriers
to disinhibited eating” in phase 3. Where pre- and postintervention scores met the test for
normality in each phase, data were analyzed using paired t-tests. Feedback from clients was
evaluated by looking at the themes of the participants’ comments, and looking at the numbers
of people who said that the course was helpful regarding the management of their diabetes.
Procedure
There were four phases of the service development, with adaptations made throughout
regarding recruitment and the intervention offered. A key aim was that adaptations made
would remain within the boundaries of IAPT Step 2 interventions. The practitioners therefore
used only the following interventions: Goal setting; Behavioural Activation; Problem Solving;
Cognitive Restructuring; Exposure Therapy; and Sleep Hygiene.
The intervention was run weekly and took place at the clients’ registered GP surgeries. The
course was run by PWPs, who at the start of the service development had no specific training
in working with people with LTC; and a PWP Lead who had specific training in working
with people with LTC. The first phase involved the standard IAPT Step 2 intervention for
depression and anxiety (see Table 1).
Each phase of the development involved running two courses, followed by analyses of
the findings, including feedback from the facilitators and clients. Course facilitators were
asked for general feedback (during clinical supervision sessions) as well as to consider issues
around engagement; nonattendance; the extent to which clients were taking part in course
work; and homework tasks, and the extent to which the clients appeared to grasp the concepts
discussed in the sessions. Clients were asked to complete an anonymous “Patient Experience
Questionnaire”, which asked them to state the most and least helpful things about the course.
For phases 3 and 4, participants were also asked whether or not the course had been helpful
regarding management of their diabetes (yes /no), and if so how. Courses run were then
adjusted accordingly. The service development included four phases.
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Table 2. Ages and pre-intervention levels of depression and anxiety in clients attending each phase of
the service development
Clients who opted into the
group, but who did not
attend any of the sessions
Clients who opted into the
group and attended half or
less of the sessions
Clients who opted into the
group and attended more
than half of the sessions
Mean Mean Mean
Phase 1 N = 3 N = 6 N = 12
Age 67.30 Age 61.83 Age 64.08
HbA1c 7.33 HbA1c 7.65 HbA1c 7.66
PHQ 5.83 PHQ 7.27
GAD 5.17 GAD 5.45
Phase 2 N = 9 N = 7 N = 15
Age 66.56 Age 60.71 Age 60.64
HbA1c 7.29 HbA1c 7.53 HbA1c7.22
PHQ 5.83 PHQ 7.27
GAD 5.17 GAD 5.45
Phase 3 N = 10 N = 4 N = 9
Age 60.00 Age 74.67 Age 60.11
HbA1c 8.51 HbA1c 8.16 HbA1c 8.44
PHQ 8.75 PHQ 11.56
GAD 5.75 GAD 8.67
Phase 4 N = 3 N = 6 N = 11
Age 60.00 Age 55.91 Age 52.62
HbA1c 9.20 HbA1c 8.23 HbA1c 9.14
PHQ 13.32 PHQ 14.75
GAD 10.67 GAD 10.38
The National Research Ethics Service was contacted regarding this work and the authors
were advised that ethical approval was not required.
Results
Analyses of preintervention measures
Preintervention measures between clients with different attendance rates are presented in
Table 2 for visual analysis. Statistical analyses were not conducted due to the low numbers
of participants. Visual analysis would suggest a trend for higher PHQ and GAD scores in
phases 3 and 4 than in phases 1 and 2. This is likely due to a more accurate method of
recruitment/selection of the participants.
Findings from, and developments of, each phase
Table 3 provides a summary of the findings from psychological outcome measures and
the findings regarding management of diabetes (self- report and HbA1). Patient feedback
is discussed in each section. In phases 1 and 2, this was obtained only for those who
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Table 3. Summary of the findings using paired t-tests (positive findings are in bold)
Phase General measures of:
depression (PHQ9;
range 0–27, with
higher scores
representing greater
severity); and
anxiety (GAD7;
range 0–21
with higher scores
representing greater
severity)
Diabetes specific
psychological
measure (Diabetes
Health Profile-
DHP) (measuring
psychological
distress;
disinhibited eating
and barriers to
activity; each range
0–100 with higher
scores representing
greater difficulties)
Self-report measure
of management of
diabetes (SDSCA
–measuring:
general diet;
specific diet;
frequency of
exercise; frequency
of blood sugar
testing; and
frequency of taking
prescribed
medication; each
range 0–7 with
higher scores
representing better
management)
HbA1c
Completed every
session, so the first
and last scores were
used
Completed only by
those attending
session 1 and final
session of groups in
phases 3 and 4
Phase 1 N = 18
No change in
depression (PHQ9,
t[17] = 1.60, p =
.13) or anxiety
(GAD7, t[17] =
1.68, p = .11)
Not asked at this
stage of the service
development
Not asked at this
stage of the service
development
N = 17
Non significant
reduction from
mean 7.65 [1.62]
to mean 7.62
[2.38], t[17] =
0.07, p = .95
Phase 2 ∗Trend in
improvements in
measurements of
depression N = 22
(PHQ9, t[21] = 1.93,
p = .07) and
anxiety (GAD7,
t[21] = 2,23, p =
0.04)
Not asked at this
stage of the service
development
Not asked at this
stage of the service
development
N = 21
Non significant
reduction from
mean 7.46 [0.99]
to mean 7.38
[1.12], t[20] =
0.58, p = .57
Phase 3 N = 13
∗∗Significant
improvements in
measurements of
depression (PHQ9,
t[12] = 2.81, p =
.02) and anxiety
(GAD7, t[12] =
2,40, p = .03)
ˆN = 7
∗Trend in
improvements in
psychological
distress (p = .1)
ˆN = 7
∗Improvement in foot
care (t[6] = 2.43, p
= .05).
N = 9
Non significant
reduction from
mean 8.33 [1.80]
to mean 8.20
[1.88], t[8] =
0.39, p = .70
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Table 3. Continued.
Phases 4
and 4(ii)
N = 17
∗∗Significant
improvements in
measurements of
depression (PHQ9,
t[16] = 3.38, p =
.04) and anxiety
(GAD7, t[16] =
2.77, p = .01)
ˆN = 9
∗∗Significant
improvements in
disinhibited eating
(t[8] = 4.44, p =
.002).
∗Trend in
improvements in
psychological
distress (p = .10).
ˆN = 9
∗∗Significant
improvements in
frequency of
exercise (t[8] =
4.00, p = .004).
∗Trend in
improvements in
specific diet (t[8] =
2.09, p = .07) and
general diet (t[8] =
1.80, p = .11).
In the feedback
questionnaire, all
clients reported that
their management
of diabetes had
improved.
N = 11
∗∗ significant
reduction in
HbA1cfrom
mean 8.76 [2.31]
to mean 7.67
[1.74], t[10] =
2.38, p = .04
∗ mean changes in scores from pre- to postintervention show a trend;
∗∗ significant changes, p<.05
ˆThe sample sizes for the DHP and SDSCA are lower than that of the PHQ and GAD; this is because
PHQ and GAD were completed every session whereas DHP and SDSCA were completed only at first
and last sessions. HbA1c scores were obtained for all who blood test results
attended the final session (a biased sample); its use for these phases was therefore limited.
The development of the service was focused on outcome measures and feedback from the
facilitators in supervision sessions with the clinical health psychologist.
Phase 1
The first two courses (Phase 1) were run as a standard Step 2 intervention focusing on
depression and anxiety. Attendance was poor; there were no significant changes in mood
(PHQ or GAD); there were no changes in HbA1c. Analysis of the patient experience
questionnaire identified the theme of patients not understanding why they were on the course;
or why the course was for people with diabetes, but focused on depression and anxiety.
Some participants stated that the course was “interesting”, “particularly the session on worry”.
Facilitators also reported that the course did not appear to be adequately tailored to the needs
of people with T2DM.
Phase 2
In response to the findings from Phase 1, the following two courses (Phase 2) were adapted
such that the work on depression and anxiety was more relevant to people living with diabetes.
During the running of Phase 2, a specialist clinical health psychologist was introduced,
to consider possible adaptations, as well as to offer weekly supervision to the facilitators.
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Attendance was poor; there was a trend in improvements in mood measures (PHQ and GAD);
and there were no changes in HbA1c. Feedback suggested that clients found the course useful
and interesting: “the material was useful and helpful for low mood”. However, clients also
raised the theme of not understanding the purpose of the course, or why they were there.
Some reported that they do not have low mood or worries. The facilitators reported that
participants generally found it difficult to identify with the idea that mood can have an impact
on management of diabetes.
Phase 3
A few adaptations were made at this point. Only clients currently prescribed anti-depressant
medication were invited to the group. These clients also received an introductory phone
call about the course from the GP involved in the project. The course protocol was
developed further so that content was more relevant to mood and diabetes. Outcome measures
were included: self-report measure of diabetes management, and diabetes specific mood
questionnaire. Clinical Health Psychology supervision was offered to help the facilitators
think about engaging clients in the intervention, and adapting the intervention so it is relevant
to those attending. It is worth highlighting that a primary goal was that the interventions were
within the boundaries of Step 2 interventions. The role of the clinical health psychologist was
to help PWPs adapt their work so that it was relevant to people living with T2DM. Finally, the
facilitators gained further knowledge of T2DM itself (from input from a GP).
Attendance was somewhat improved; there were significant improvements in mood
measures (PHQ and GAD); there were trends suggesting improvements in management of
diabetes, but no significant changes in HbA1c. Observation of feedback from the clients
generated a theme around the course being helpful in thinking about how low mood affects
the way people manage their diabetes, which was reported by about half the clients who
completed the feedback form. Feedback from facilitators suggested that clients were more
engaged with the work and were able to make the link between mood and management of
diabetes.
Phase 4
Due to the difficulties with engagement in the work and attendance rates, some significant
changes were made with respect to recruitment and the way in which the group was conducted.
These are described below:
- Clients who were on anti-depressants were invited to course 7; the letter more clearly
described the aim of the course;
- All individuals who responded to the letters received an introductory phone call from course
facilitators.
- The course content was amended, so that it was immediately relevant to “living with
diabetes” and, although work was contained in the standard step 2 IAPT intervention, work
on depression and anxiety was continuously related to living with and managing diabetes.
- The workbooks were simplified.
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- The facilitators used core CBT competences discussed in clinical supervision; in particular
they used a more socratic, open, discursive approach as opposed to the didactic approach
usually used in the Wellbeing Course.
- More clinical supervision was offered to facilitate this style of working.
Facilitators reported that clients engaged with the work and were able to make the link
between mood and management of diabetes. All clients who completed the course made a
comment on the form around the theme that the course was very helpful. For example, one
participant said that she was doing more exercise to help her diabetes; another said that she had
started going for more walks with her neighbour; and another had worked out how to leave her
dog alone at home so she could go to gym. Three participants said that they were able to use
the activities to socialize more, which helped improve their mood. All clients who completed
the form stated “yes” to the question whether or not the course was helpful regarding their
management of their diabetes. There were significant improvements in measures of mood,
and in self-report management of diabetes, which were also reflected in improvements in
HbA1c.
Conclusions
The findings suggest that the standard IAPT Step 2 intervention was not initially effective
for this patient group. However, the findings suggest that it is possible to modify the Step
2 intervention in such a way that it used only IAPT Step 2 interventions, but was effective
for people living with T2DM both in terms of mood and self-management. The adaptations
focused on appropriately selecting individuals for the course and adapting Step 2 interventions
to make links between mood and the way in which T2DM is managed. These findings support
the argument that psychological work focusing specifically on depression and anxiety may be
effective regarding diabetes management e.g. Lamers et al., 2011; Snoek et al., 2008.
Summary of the service development
This paper describes the development of a Step 2 service that can be offered by IAPT to
support people living with LTCs. The service development included four phases during which
the course was modified reflecting feedback from clients and facilitators as well as outcome
measures. The findings suggest that the standard Step 2 intervention was limited in terms
of (i) engaging this client group; and (ii) helping clients understand the link between mood
and bodily symptoms related to their T2DM. However, with careful analyses of feedback and
outcome measures, the Step 2 intervention was adapted so that it was specifically tailored to
the participants, but still remained in the boundaries of Step 2 interventions. The final phase
demonstrated improvements in general measures of depression and anxiety; diabetes specific
measures, self-report management of diabetes, as well as physiological measures including
HbA1c which is the main measure of diabetic control. The dropout rates were considered
throughout the pilot. In phase 4, 65% people who attended session 1 went on to complete
5 or 6 sessions. Although this figure appears low, it is comparable to previous findings in a
general IAPT service. For example, in the IAPT demonstration site in Doncaster, Clark et al.
(2009) found that of those offered low intensity treatments, 34% dropped out of treatment or
discontinued.
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The findings suggest improvements in engagement and outcome measures as the
intervention developed. Results are encouraging. In the final phase, clients appear to engage
with the work and appeared able to make the link between mood and management of
diabetes. Outcome measures from this final course demonstrated some improvements in
measures of depression and anxiety, as well as in psychological measures specific to diabetes
(psychological barriers; and disinhibited eating); and in self-care measures, namely frequency
of exercising. Furthermore there was a trend regarding self-care (specific diet; and frequency
of taking prescribed medication). Encouragingly, there was also a significant improvement in
medical measures (HbA1c). Furthermore, all clients who completed the course said that they
found it helpful and reported that they had made changes resulting in improved mood and
management of diabetes. It is possible, however; that there is a bias in the client feedback as,
although the questionnaire was anonymous, clients may have felt that they wanted to “please”
the facilitators. For this reason, and the fact that the form was completed only by those who
attended the final session, greater emphasis was placed on the feedback from facilitators and
the standardized outcome measures.
Limitations of the work
The numbers of participants in each phase was low, meaning that full statistical analyses
were not conducted. In particular, it would be helpful to have more participants in Phase 4 of
the service development, to allow a fuller evaluation of the effectiveness of this intervention.
Due to the small number of participants, it is also not possible to evaluate mediators of any
of the changes. A randomized control trial would also be helpful to evaluate the effectiveness
of the specific intervention over treatment as usual. A further limitation is the lack of any
follow-up; it is not possible to know whether improvements would continue, or decline. It
is hoped that improvements may continue to be made over the following few months, as
was demonstrated in a study by van der Ven et al. (2005), who showed no improvements in
glycaemic control at 3 months and 6 months. However, the study was followed up by Snoek
et al. (2008), and demonstrated improvements in glycaemic control at 1-year follow-up. It is
possible that the reason that this intervention showed a more immediate effect is because it
focused on mild to moderate depression and participants were ready to join a group in order
to make changes to improve their mood.
Findings in relation to IAPT
The adaptations to the course protocol focused mainly on two aspects. First, engagement
appeared paramount. In the generic course, the first sessions focuses on psychoeducation
about anxiety and depression. In the modified version, the focus was more Socratic, and
facilitated discussion about living with diabetes. The second main adaptation focused on
helping clients to think about the ways in which their thoughts and behaviours, specifically
about diabetes, formed a vicious cycle with mood and physiological symptoms related to
diabetes. It seemed that encouraging clients to make this link helped them challenge less
helpful coping strategies, such as “eating chocolate biscuits”, when feeling down, and as a
result experiencing more critical thoughts about oneself regarding his/her ability to manage
the diabetes. In phase 4, clients reported that they found this link easier to make, and therefore
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to make changes in ways that helped both mood and management of diabetes. This was also
reflected in the outcome measures.
Conclusions and future directions
The main question addressed by this paper is whether IAPT interventions that are evidence-
based for the treatment of mild to moderate depression and anxiety can be effective for
people with long term medical conditions. The findings from this service development are
encouraging. With the expansion of IAPT’s involvement in working with people with LTCs
(as well as Medically Unexplained Symptoms), the authors would like to highlight the need
for the involvement of health professionals with specific expertise in working with this client
group (in this case, the GP and specialist clinical health psychologist), who offered ongoing
input and supervision to ensure that the intervention was appropriately tailored, but remained
within the boundaries of Step 2 IAPT interventions for mild to moderate anxiety/depression.
It is concluded that in order for standard IAPT interventions to be effective, adaptations need
to be made such that the interventions are specifically tailored to the condition in question,
with PWPs attending specific training in working with people with LTC and with input from
health professionals with expertise in the medical condition, in this case a GP and a specialist
clinical health psychologist.
The current group are extending this research by conducting a randomized control trial
to systematically investigate the effectiveness of a specifically tailored intervention with
respect both to measures of mood and physiological measures. Clearly, further research is
also required to investigate whether the findings in offering interventions to clients with other
long term medical conditions can be generalized to a wider client base.
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